| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/13/2006 | CN1274324C Preparation method of Chinese medicinal eye drops for treating myopia |
| 09/13/2006 | CN1274323C Wind expelling, toxin removing bone reaching powder |
| 09/13/2006 | CN1274321C Astragalus injection Chinese medicinal preparation and its preparation method |
| 09/13/2006 | CN1274317C Remedies for dermatophytosis |
| 09/13/2006 | CN1274314C Health care food for defatting |
| 09/13/2006 | CN1274313C Preparation method of clindamycin phosphate powder injection |
| 09/13/2006 | CN1274311C Application and formulation of dammarane type gen-seng low valence alcohol derivative |
| 09/13/2006 | CN1274310C Paste agent of penetrating through skin for treating arthritid and preparation method |
| 09/13/2006 | CN1274309C Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 09/13/2006 | CN1274308C Prostatic atrophy antiphlogistic injection liquid |
| 09/13/2006 | CN1274304C Etomidate fatty emulsion injection preparation method |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/13/2006 | CN1274299C Doxy rhodol magnetic microglobule and its making method |
| 09/13/2006 | CN1274298C Disintegrants for deodoring effectively and their preparation |
| 09/13/2006 | CN1274297C Composition and drug form for curing oral nosomycosis |
| 09/13/2006 | CN1274296C Method for producing water dispersible dry powders from poorly soluble compounds |
| 09/13/2006 | CN1274295C Method for preparing oral slow/coutrolled release medicinal micro granule |
| 09/13/2006 | CN1274294C Novel cyclosporin analog microemulsion preconcentrates |
| 09/13/2006 | CN1274293C Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 09/13/2006 | CN1274243C Hair tonic amino acid and its preparation method |
| 09/13/2006 | CN1274235C Anti-dental caries chewing gum and preparation |
| 09/12/2006 | US7107106 System and method for collecting data and managing patient care |
| 09/12/2006 | US7105699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 09/12/2006 | US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/12/2006 | US7105574 Composition of GAP DMORIE and colipids; adjuvant of cytofectin and neutral lipid such as a phosphatidylethanolamine provide elevation of antibody levels particularly in applications where antibody levels from the immunogen-encoding polynucleotide alone are sub-optimal |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105571 Substituted aminoalkanoate or substituted aminoalkyl alkanoate as a penetration enhancer a shear-thinning polysaccharide, a lipophilic compound, and an acidic buffer system. |
| 09/12/2006 | US7105512 Having anti- inflammatory effect, which is less irritant, which has high safety and storage stability |
| 09/12/2006 | US7105490 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105489 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105480 Administering a leptin or derivative, homologue, analogue, chemical equivalent or agonist to inhibit, reduce or delay onset or progression of bone resorption; treatiing osteoporosis and Paget's disease |
| 09/12/2006 | US7105478 Rigid framework with two openings on different sides, each opening being closed by a film; the rigid framework forming the edges of the container containing a dishwashing, fabric care, surface care, disinfectant, antibacterial, antiseptic or agricultural composition |
| 09/12/2006 | US7105229 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 09/12/2006 | US7105188 Fermentation solution of a sugar component, water, and a pine leaf cluster; allowing fermentation solution to stand for a period of time; treating atopic dermatitis and athlete's foot |
| 09/12/2006 | US7105182 Periodontal regeneration composition and method of using same |
| 09/12/2006 | US7105181 Microparticles |
| 09/12/2006 | US7105180 Storage stability; bioavailability; core containing drug such as omeprazole, enteric overcoating |
| 09/12/2006 | US7105179 Crystal forms of azithromycin |
| 09/12/2006 | US7105178 Cardiotonic composition |
| 09/12/2006 | US7105176 Dissolving or dispersing active compounds in aqueous or colloidal dispersion of a proteinaceous protecting colloid, flocculating with active compound out of dispersion separating off flocculated solid; forming dry powder |
| 09/12/2006 | US7105174 Multiple-delayed release anti-neoplastic product, use and formulation thereof |
| 09/12/2006 | US7105173 Nicotine delivery vehicle which is discrete and self-administered; composition of wax and nicotine packaged in a cosmetic stick |
| 09/12/2006 | US7105172 Treatment of rosacea |
| 09/12/2006 | US7105162 Peptide or protein from a pathogenic or tumor agent having immunomodulatory activity with an adjuvant capable of increasing the binding of the peptide to the cells of the individual or increasing the entry of the peptide into the cells; strengthening immunomodulatory activity; polyamino acids adjuvants |
| 09/12/2006 | US7105161 Proteinaceous adjuvants |
| 09/12/2006 | US7105158 Methods of administering microencapsulated materials for immune modulated diseases |
| 09/12/2006 | US7105154 Orally administering interferon-tau to intestinal tract to produce measureable increase in patient's blood level of 2*,5*-oligoadenylate synthetase (OAS); autoimmune disease, viral infection and cancer treatment |
| 09/12/2006 | US7105153 Thickener-rheology modifier system for personal care compositions |
| 09/12/2006 | US7105152 Suspension aerosol formulations |
| 09/12/2006 | US7105151 Oxygen delivery agents and uses for the same |
| 09/12/2006 | US7104988 Cardiac drug delivery system |
| 09/12/2006 | US7104968 Applicator device for suppositories and the like |
| 09/12/2006 | CA2375652C Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 09/12/2006 | CA2346539C Compositions and methods for enhancing receptor-mediated cellular internalization |
| 09/12/2006 | CA2315110C Pellets having a core coated with an antifungal and a polymer |
| 09/12/2006 | CA2312545C Solid, thermoformable, controlled-release pharmaceutical compound |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/12/2006 | CA2298259C Basic drug compositions with enhanced bioavailability |
| 09/12/2006 | CA2268811C Vitamin delivery |
| 09/12/2006 | CA2240684C Aerosol preparation |
| 09/12/2006 | CA2195881C Stabilization of colloidal systems through the formation of lipid-polysaccharide complexes |
| 09/12/2006 | CA2194774C Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
| 09/12/2006 | CA2194576C Long-acting oxytetracycline composition |
| 09/12/2006 | CA2189991C Active substance controlled release devices and process for producing the same |
| 09/11/2006 | CA2536430A1 Cosmetic emulsions with long-term stability |
| 09/08/2006 | WO2006094203A1 Mitochondriotropic phospholipid vesicles |
| 09/08/2006 | WO2006094083A1 Controlled release venlafaxine formulations |
| 09/08/2006 | WO2006093758A1 Microimplants for ocular administration |
| 09/08/2006 | WO2006093537A1 Use of a volatile rhinological effective composition on fibrous tissues to provide a sensation of sinusoidal relieve |
| 09/08/2006 | WO2006093390A1 Nonporous microspheres including drug and manufacturing method thereof |
| 09/08/2006 | WO2006093353A1 Release-control composition |
| 09/08/2006 | WO2006093222A1 Inhibitor for insulin polymer formation |
| 09/08/2006 | WO2006093139A1 Transdermally absorbable preparation |
| 09/08/2006 | WO2006093066A1 Pressure-sensitive adhesive base and medical adhesive patch including the pressure-sensitive adhesive base |
| 09/08/2006 | WO2006092829A1 External plaster containing flurbiprofen |
| 09/08/2006 | WO2006092607A1 Pharmaceutical composition |
| 09/08/2006 | WO2006092585A2 Personal lubricant containing polyethylene oxide |
| 09/08/2006 | WO2006092581A1 Lubricating composition |
| 09/08/2006 | WO2006092569A1 Production process for nsaid-containing lozenges, their compositions, their medicinal use |
| 09/08/2006 | WO2006092295A1 Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support |
| 09/08/2006 | WO2006092255A1 Pharmaceutical composition comprising an indolylmaleimide derivative |
| 09/08/2006 | WO2006092222A1 Medicament forms with controlled bioavailability |
| 09/08/2006 | WO2006092207A1 Pharmaceutical forms with improved pharmacokinetic properties |
| 09/08/2006 | WO2006092168A1 Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter |
| 09/08/2006 | WO2006092155A1 Preparation with anti-microbial action for external use |
| 09/08/2006 | WO2006092064A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 09/08/2006 | WO2006081279A3 Control of drug release by transient modification of local microenvironments |
| 09/08/2006 | WO2006074185A3 Taste masking system for non-plasticizing drugs |
| 09/08/2006 | WO2006069911A3 Mucoadhesive pharmaceutical compositions comprising chemoattractants |
| 09/08/2006 | WO2006060711A3 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition |
| 09/08/2006 | WO2006060213A3 Storage stable compositions for biological materials |
| 09/08/2006 | WO2006056145A3 Osmotic device containing a venlafaxine salt and a salt having a common ion |
| 09/08/2006 | WO2006053006A3 Retinoid solutions and formulations made therefrom |
| 09/08/2006 | WO2006047409A3 Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds |
| 09/08/2006 | WO2006019881A3 Compositions and methods for controlling biofilms and bacterial infections |
| 09/08/2006 | WO2006010394A3 Medicament in a multilayer form |
| 09/08/2006 | WO2005107846A3 Packaging for a therapeutic agent, consisting of a covering film, a non-woven film, and a therapeutic agent layer |
| 09/08/2006 | WO2005053619A3 Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal |
| 09/08/2006 | WO2004089290A3 Novel probiotic compositions and methods of using the same |
| 09/08/2006 | WO2003028696A8 Compositions for delivery of drug combinations |